FDA approves risk evaluation and mitigation strategy (REMS) modification, advancing new drug disposal option for opioid analgesics.
FDA approves risk evaluation and mitigation strategy (REMS) modification, advancing new drug disposal option for opioid analgesics.
No comments yet. Be the first to share your thoughts.